Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).

[1]  Douglas G. Altman,et al.  Assessing the Quality of Randomised Controlled Trials , 2008 .

[2]  R. Garfein,et al.  Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. , 2007, Drug and alcohol dependence.

[3]  Steffanie A Strathdee,et al.  A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users , 2007, AIDS.

[4]  Nicole Crepaz,et al.  Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team. , 2006, AIDS education and prevention : official publication of the International Society for AIDS Education.

[5]  B. Branson,et al.  A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status , 2006, AIDS.

[6]  Susan G. Sherman,et al.  The role of sexual transmission of HIV infection among injection and non-injection drug users , 2003, Journal of Urban Health.

[7]  Lu Yin,et al.  HIV Incidence and Factors Contributed to Retention in a 12-Month Follow-up Study of Injection Drug Users in Sichuan Province, China , 2005, Journal of acquired immune deficiency syndromes.

[8]  D. Vlahov,et al.  Childhood sexual abuse and age at initiation of injection drug use. , 2005, American journal of public health.

[9]  D. Metzger,et al.  Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. , 2005, Addiction.

[10]  S. Kellerman,et al.  Changes in HIV and AIDS in the United States: Entering the third decade , 2005, Current HIV/AIDS reports.

[11]  Y. Gilleece,et al.  Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? , 2004, Sexually Transmitted Infections.

[12]  A. Lansky,et al.  Failure to Return for HIV Test Results Among Persons at High Risk for HIV Infection: Results From a Multistate Interview Project , 2004, Journal of Acquired Immune Deficiency Syndromes.

[13]  D. Heckathorn,et al.  Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.

[14]  M. Alter,et al.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  M. Busch,et al.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.

[16]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[17]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[18]  D. Vlahov,et al.  Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. , 2001, Archives of internal medicine.

[19]  P. Bacchetti,et al.  Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis , 2001, The Lancet.

[20]  D. Vlahov,et al.  Factors Associated with Adolescent Initiation of Injection Drug Use , 2001, Public health reports.

[21]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[22]  L. Thorpe,et al.  Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. , 2000, The Journal of infectious diseases.

[23]  D S Metzger,et al.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. , 2000, American journal of epidemiology.

[24]  B. Edlin,et al.  The effect of syringe exchange use on high-risk injection drug users: a cohort study , 2000, AIDS.

[25]  K. Marder,et al.  Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users. , 1999, The American journal of drug and alcohol abuse.

[26]  Heather Miller,et al.  Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.

[27]  R. Wejstål.  Sexual transmission of hepatitis C virus. , 1999, Journal of hepatology.

[28]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[29]  F Rhodes,et al.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. , 1998, JAMA.

[30]  F Rhodes,et al.  What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an HIV/STD prevention counselling intervention. The Project RESPECT Study Group. , 1998, Sexually transmitted infections.

[31]  R. Booth,et al.  Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. , 1998, Journal of psychoactive drugs.

[32]  D. Celentano,et al.  Preventing HIV infection: the effects of community linkages, time, and money on recruiting and retaining women in intervention groups. , 1998, Journal of women's health.

[33]  S. M. Rogers,et al.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. , 1998, Science.

[34]  D. Vlahov,et al.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[35]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[36]  D. Vlahov,et al.  Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. , 1996, The Journal of infectious diseases.

[37]  B. Jovanovic,et al.  Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[38]  D. Vlahov,et al.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.

[39]  S. Tortu,et al.  The impact of providing incentives for attendance at AIDS prevention sessions. , 1994, Public health reports.

[40]  H. Wolfe,et al.  Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. , 1994, AIDS research and human retroviruses.

[41]  R. Valdiserri,et al.  A study of clients returning for counseling after HIV testing: implications for improving rates of return. , 1993, Public health reports.

[42]  W A Fisher,et al.  Changing AIDS-risk behavior. , 1992, Psychological bulletin.

[43]  A Munoz,et al.  The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.

[44]  D. Vlahov,et al.  Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. , 1990, American journal of epidemiology.

[45]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.

[46]  W. El-Sadr,et al.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. , 1987, AIDS.

[47]  R. Chaisson,et al.  Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. , 1987, American journal of public health.

[48]  Y. Hser,et al.  Sex differences in addict careers. 1. Initiation of use. , 1987, The American journal of drug and alcohol abuse.